We passionately improve health

Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.

Our Company

Annual Report 2017

For over 130 years, Boehringer Ingelheim has continuously undergone change. Read more how agility drives us in our Annual Report 2017.

Read more on Annual Report 2017

Research & Development

What We Focus On

Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.

Read more on What We Focus On
Drug Discovery Process

How We Discover

Drug Discovery Process

From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion.

Read more on

Drug Discovery Process

Pharmacovigilance (PV)

Mission of Pharmacovigilance (PV)

To provide high quality science-based proactive risk management strategies and operational excellence in a fully compliant global pharmacovigilance system with the ultimate goal to safeguard patients´ well-being and thus protect the company.

Read more on Mission of Pharmacovigilance (PV)
whistleblowing_kachel

Compliance

Speak Up!

We’re committed to compliance. Learn more about our Compliance and Speak up culture.

Read moreon

Speak Up!

Explore Our Content